A recent study published in Springer May 2025 Experimental Brain Research has demonstrated the effectiveness of NovaVision's NeuroEyeCoach in improving visual search performance and reducing visual disability among patients, regardless of whether the therapy was accessed at home or in a clinic setting. This study, a collaboration between the University of Verona, Italy, and NovaVision, compared outcomes for 95 patients using the therapy at home with 31 patients in a clinic setting, finding no significant differences in the benefits received by either group.
The NeuroEyeCoach program, designed for both clinic and home use, addresses the need for accessible vision rehabilitation solutions. With variations in rehabilitation provisions across Europe and the US, the program's low-cost delivery model aims to widen access to effective therapy. The study's findings support the growing trend towards digital health solutions that can be accessed remotely, offering hope for patients with visual impairments due to stroke or brain injury.
Objective measures from the study showed improvements in visual function, including reduced search times and errors, alongside subjective reports of decreased disability. These results underscore the potential of NeuroEyeCoach to serve as a standard of care in saccadic training, providing a viable option for patients seeking to regain visual capabilities outside traditional clinical settings.
